Everything You Need to Know About RBQM

RBQM risk evolution across the clinical trial lifecycle

Learn what RBQM (Risk-Based Quality Management) is, how it works, and how to apply it in clinical trials using practical guidance, examples, and resources.

FDA Risk-Based Inspections: Move Risk Detection Upstream

FDA’s risk-based inspection approach raises a practical question: if protocol deviations and data anomalies can help regulators determine where to look, how can sponsors use related signals earlier – while there is still time to act?

Making RBQM Work in Practice: Adam Baumgart

What does it take to make RBQM work consistently in practice? Adam Baumgart discusses implementation, AI, cross-functional oversight and the customer experience required to turn risk signals into meaningful action.

Explainable AI in Clinical Trials

Clinical trial AI should do more than detect patterns. It must help teams understand, challenge, and document the rationale behind risk signals. Cyntegrity’s latest research reference explores how explainable mathematical discovery can support the next generation of RBQM innovation.

AI Literacy in Clinical Trials Under ICH E6(R3)

AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use.